關鍵數據
1.290今開
1.330最高
16.57K成交量
虧損本益比TTM
9.50本益比動
--股利TTM
0.12%換手率
1.240昨收
1.270最低
21.63K成交額
虧損本益比靜
3.14市淨率
0.00%股息率 TTM
-53.58%ROA
1.66052週最高
0.01量比
-17.76M淨利潤
14.21M總股本
-0.9689每股盈餘TTM
0.85Beta
-339.04%ROE
0.55552週最低
4.43%振幅
79.51%毛利率
18.68M總市值
4.90回報/風險
5.07%風險率

即將為您帶來更多新聞,敬請期待。 。 。
Biofrontera Inc評分
0.28與上次評分對比預測8.00
財務診斷8.64
技術分析6.13
公司估值8.21
機構認同度3.00
風險評估3.20
分析師評級
買入評級
6.000目標均價
+383.87%漲幅空間
Biofrontera Inc 最新財報電話會記錄
Biofrontera (BFRI) 2026 年第二季法說會:營收成長 33%,毛利率達 80%
Biofrontera 的 2026 年第二季財報電話會議涵蓋了 33% 的營收成長、80% 的毛利率、調整後 EBITDA 接近損益兩平、ITC 限制以及 Ameluz 的里程碑。
財務指標
貨幣: USD

由於公司未披露,未能獲取相關數據
貨幣: USD

由於公司未披露,未能獲取相關數據
Biofrontera Inc 簡介
Biofrontera Inc. is a biopharmaceutical company. The Company specializes in the development and commercialization of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT). The PDT treatment is used for the lesion-directed and field-directed treatment of actinic keratoses of mild-to-moderate severity on the face and scalp. The Company’s primary licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (the RhodoLED Lamps), are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions. The Company commercializes the drug-device combination Ameluz with the RhodoLED lamp series for PDT of AK, pre-cancerous skin lesions which may progress to invasive skin cancers. Its belixos ACTIVE CARE is a skin-soothing care foam for irritated and itchy skin, which can be used as basic care for atopic dermatitis and psoriasis as well as for soothing intensive care for everyday skin problems.
行業藥品
公司代碼BFRI
員工數量92
國家United States of America
持股情況
| 持股股東 | 佔比 |
|---|
| Rosalind Advisors, Inc. | 9.50% |
|---|
| AIGH Capital Management, LLC. | 5.80% |
|---|
| Hewlett Fund, L.P. | 3.93% |
|---|
| Biofrontera AG | 3.33% |
|---|
| 股東類型 | 佔比 |
|---|
| Hedge Fund | 12.10% |
|---|
| Corporation | 7.26% |
|---|
| Individual Investor | 6.43% |
|---|
| Private Equity | 6.29% |
|---|
常見問題
Biofrontera Inc(BFRI)的當前股價是多少?
Biofrontera Inc(BFRI)的當前股價是 1.32。
Biofrontera Inc 的股票代碼是什麼?
Biofrontera Inc的股票代碼是BFRI。
Biofrontera Inc股票的52週最高點是多少?
Biofrontera Inc股票的52週最高點是1.66。
Biofrontera Inc股票的52週最低點是多少?
Biofrontera Inc股票的52週最低點是0.56。
Biofrontera Inc的市值是18.68M。
現在Biofrontera Inc(BFRI)的股票是買入、持有還是賣出?
根據分析師評級,Biofrontera Inc(BFRI)的總體評級為買入,目標價格為6.00。
Biofrontera Inc(BFRI)股票的每股收益(EPS TTM)是多少
Biofrontera Inc(BFRI)股票的每股收益(EPS TTM)是-0.97。